Company Profile: Strategic Medicine, Inc. and Strategic Medicine, BV

Personalized Medicine
Michael N Liebman

Abstract

Strategic Medicine, BV (The Hague, The Netherlands) and Strategic Medicine, Inc. (PA, USA) deliver products and services to therapeutic and diagnostic companies, healthcare providers and payers and the investment community based on unique methodologies for modeling disease processes, from predisease through diagnosis, disease and patient stratification and outcome. Strategic Medicine, Inc. focuses on the development of disease models that design and incorporate a personalized health record to model the progression of a patient from genetic risk, through interaction with lifestyle and environment, to early disease detection, disease and patient stratification and treatment decision support for enhanced outcomes. This model involves the integration of disparate data and databases, evaluation of data quality and completeness, data simulation (when necessary), systems modeling and quantitative risk/opportunity evaluation. Strategic Medicine, Inc. has been involved in applying these approaches in oncology, cardiology, women's health and pediatric conditions and rare diseases, and has focused on the development of both disease- and data-agnostic infrastructures and analytics.

References

Jul 29, 2006·IEEE Transactions on Information Technology in Biomedicine : a Publication of the IEEE Engineering in Medicine and Biology Society·Susan M MaskeryMichael N Liebman
Feb 12, 2008·Journal of Biomedical Informatics·Susan M MaskeryMichael N Liebman
Dec 6, 2008·International Journal of Cancer. Journal International Du Cancer·Dejana BraithwaiteLaura Esserman
Jul 15, 2009·Methods in Molecular Biology·Michael Liebman
Mar 12, 2010·Arthritis and Rheumatism·Margalit E RosenkranzRaphael Hirsch
Aug 30, 2011·Journal of Biomedical Informatics·Hai HuRichard J Mural
Oct 27, 2011·Technology and Health Care : Official Journal of the European Society for Engineering and Medicine·Christine Huttin, Michael Liebman
Mar 29, 2012·Journal of Translational Medicine·Michael N Liebman, Francesco M Marincola
May 16, 2012·Journal of Translational Medicine·Valeria SicilianoSabrina Molinaro
May 31, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·June Koo LeeDae Seog Heo
Oct 19, 2012·Journal of Translational Medicine·Michael N Liebman, Sabrina Molinaro
Mar 21, 2013·Technology and Health Care : Official Journal of the European Society for Engineering and Medicine·Christine C Huttin, Michael N Liebman

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping

Software Mentioned

SMI
IPQ Analytics

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Healthcare Informatics : the Business Magazine for Information and Communication Systems
Mark Hagland
Personalized Medicine
Maher Albitar, Alfred Bacharach
Personalized Medicine
Julia R Trosman, Christine B Weldon
McGill Journal of Medicine : MJM : an International Forum for the Advancement of Medical Sciences by Students
Joseph Ferrara
© 2022 Meta ULC. All rights reserved